000 01319 a2200349 4500
005 20250517132818.0
264 0 _c20180713
008 201807s 0 0 eng d
022 _a1557-8593
024 7 _a10.1089/dia.2016.0432
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEkhlaspour, Laya
245 0 0 _aIn-Home Closed Loop Control for Artificial Pancreas: Patient and Provider Perspective.
_h[electronic resource]
260 _bDiabetes technology & therapeutics
_c01 2017
300 _a4-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAttitude of Health Personnel
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aCost of Illness
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aHealth Knowledge, Attitudes, Practice
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xprevention & control
650 0 4 _aHypoglycemia
_xprevention & control
650 0 4 _aPancreas, Artificial
_xadverse effects
650 0 4 _aQuality of Life
650 0 4 _aWireless Technology
700 1 _aMaahs, David M
773 0 _tDiabetes technology & therapeutics
_gvol. 19
_gno. 1
_gp. 4-6
856 4 0 _uhttps://doi.org/10.1089/dia.2016.0432
_zAvailable from publisher's website
999 _c26755171
_d26755171